ClinConnect ClinConnect Logo
Search / Trial NCT06836479

Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

Launched by STANFORD UNIVERSITY · Feb 14, 2025

Trial Information

Current as of June 01, 2025

Not yet recruiting

Keywords

Type 2 Diabetes Asian American Asian Indian Filipino Medically Tailored Meals Culture Culturally Tailored Meals Continuous Glucose Monitoring Nutritional Interventions Dietary Adherence Diabetes Management

ClinConnect Summary

This clinical trial is looking at how a special diet, designed for Asian Americans with type 2 diabetes, affects blood sugar levels. The researchers want to see if meals that reflect cultural preferences can help manage diabetes better, while still following general guidelines for healthy eating. To do this, participants will wear a Continuous Glucose Monitor (CGM) for one month. This device will track their blood sugar levels as they eat both their regular meals and the culturally tailored meals.

To join the study, you need to identify as Asian Indian or Filipino and have been diagnosed with type 2 diabetes. You should also be able to pick up meals from a specific location on the Stanford campus and be willing to wear the CGM for 30 days. However, if you are currently taking certain diabetes medications like insulin or have severe food allergies, you won't be eligible. This trial is not yet recruiting participants, but it aims to provide valuable insights into how personalized diets can improve health for people with diabetes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Self-identification as Asian Indian or Filipino
  • Diagnosed with T2DM
  • Can pick up meals from a designated area on the Stanford Campus
  • Willing to wear a CGM for 30 days
  • Exclusion Criteria:
  • Currently taking insulin, GLP -1 and SGLT 2
  • Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat
  • Those who, in the opinion of the investigators, cannot reliably complete the study protocol.

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Stanford, California, United States

Patients applied

0 patients applied

Trial Officials

Minal Moharir, MD

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported